EUVIMEDEUVIMED entdecken
Crossref

Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease

Maryelle A G de Carvalho, Gabriella B Souza, Tiago Tizziani, Carime L M Pontes, Bibiana P Dambrós, Natália F de Sousa, Marcus T Scotti iD, Mario Steindel, Antonio L Braga, Louis P Sandjo, Francisco F de Assis

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Maryelle A G de Carvalho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, CFM, Universidade Federal de Santa Catarina, Campus Universitario-Trindade, Florianópolis, Santa Catarina, Brazil. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Gallic Acid, Coronavirus 3C Proteases, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present work reports the inhibitory effect of amides derived from gallic acid (gallamides) against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) main protease (M pro ), along with cytotoxicity evaluation and molecular docking studies. In addition to gallamides, other relevant compounds were also synthesized and evaluated against M pro , making a total of 25 compounds. Eight compounds presented solubility issues during the inhibitory assay and one showed no inhibitory activity. Compounds 3a , 3b , and 3f showed the highest enzymatic inhibition with IC 50 = 0.26 ± 0.19 µM, 0.80 ± 0.38 µM, and 2.87 ± 1.17 µM, respectively. Selenogallamide 6a exhibited IC 50 values of 5.42 ± 2.89 µM and a comparison with its nonselenylated congener 3c shows that the insertion of the chalcogen moiety improved the inhibitory capacity of the compound by approximately 10 times. Regarding the cellular toxicity in THP‐1 and Vero cells, compounds 3e and 3g , showed moderate cytotoxicity in Vero cells, while for THP‐1 both were nontoxic, with CC 50 > 150 µM. Derivative 3d showed moderate cytotoxicity against both cell lines, whereas 6d was moderatly toxic to THP‐1. Other compounds analyzed do not induce substantial cellular toxicity at the concentrations tested. The molecular docking results for compounds 3a , 3b , and 3f show that hydrogen bonding interactions involving the hydroxyl groups (OH) of the gallate moiety are relevant, as well as the carbonyl group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationGallic AcidCoronavirus 3C ProteasesSARS-CoV-2Antiviral AgentsAmidesProtease InhibitorsHumansVero CellsChlorocebus aethiopsAnimalsStructure-Activity RelationshipComputer SimulationCOVID-19 Drug TreatmentInhibitory Concentration 50Cell Survival

Stichwörter der Autor:innen

COVID‐19Mpro InhibitorSARS‐CoV‐2gallamidesgallic acid

Substanzen

Gallic AcidCoronavirus 3C ProteasesAntiviral AgentsAmidesProtease Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, CFM, Universidade Federal de Santa Catarina, Campus Universitario-Trindade, Florianópolis, Santa Catarina, Brazil.
  • Department of Microbiology, Immunology and Parasitology, CCB, Universidade Federal de Santa Catarina, Campus Universitario-Trindade, Florianópolis, Santa Catarina, Brazil.
  • Department of Chemistry, Center for Exact and Natural Sciences, Universidade Federal de Paraíba, Campus I, João Pessoa, Paraíba, Brazil.

ORCID-Profile: Marcus T Scotti

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • CAPES

Zitieren

APA

Carvalho, M. A. G., Souza, G. B., Tizziani, T., Pontes, C. L. M., Dambrós, B. P., Sousa, N. F., Scotti, M. T., Steindel, M., Braga, A. L., Sandjo, L. P., & Assis, F. F. (2024). Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400253

Vancouver

Carvalho MAG, Souza GB, Tizziani T, Pontes CLM, Dambrós BP, Sousa NF, et al. Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400253

BibTeX
@article{Carvalho2024,
  author = {Carvalho, Maryelle A G de and Souza, Gabriella B and Tizziani, Tiago and Pontes, Carime L M and Dambrós, Bibiana P and Sousa, Natália F de and Scotti, Marcus T and Steindel, Mario and Braga, Antonio L and Sandjo, Louis P and Assis, Francisco F de},
  title = {Synthesis, in vitro and in silico evaluation of gallamide and selenogallamide derivatives as inhibitors of the SARS‐CoV‐2 main protease},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400253}
}
Kostenlos starten →